Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > New FDA Proposed Guidance on AA

<< Previous

Bullboard Posts

Next >>

Post by Donein25on Mar 28, 2023 4:25pm

991 Views

Post# 35365426

New FDA Proposed Guidance on AA

FDA floats 'one-trial' model for cancer drug approvals (fiercebiotech.com)

The link to the full statement from the FDA is inside this article. Click "outlined" to follow the link to the FDA Guidance. They seem to keep the door open to our trial design, but there is a definite shift in sentiment toward randomized trials instead. For now it is just a proposed shift, but its coming.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec